Find out what our customers have to say about our service.Read more
Briton joins eye disease cell trial
Wednesday January 25th 2012
A 34-year-old Briton has become the first European to take part in a stem cell trial for a rare eye disease.
Marcus Hilton, a long-term sufferer of severe Stargardt's macular dystrophy (SMD), a hereditary disease that causes loss of central vision, was injected with retinal pigment epithelial (RPE) cells derived from human embryonic stem cells.
He received them in an injection in a 90-minute operation at London's Moorfields Eye Hospital last Friday.
Early US results indicate the method is safe and could result in a suitable therapy, although it will take years to prove the treatment, and Mr Hilton's contribution was part of a European arm of a trial to examine safety.
He was just seven when a problem was spotted at school although he was not diagnosed with the condition until three years later.
However, the father of four-year-old daughter, Amelia, said he was thrilled and excited to be helping out with the tests.
Copyright Press Association 2012
Our Health Cash Plan helps you and your family manage the costs of everyday routine health care, and offers you the choice of whether you use the NHS or go private.